SLS

SELLAS Life Sciences Group, Inc.

$8.03−0.39 (−4.63%)Close Nov 12, 2026

Mar 12, 2008 – Nov 12, 2026, Dividends reinvested

Final balance: $0.25
CAGR: −43.25%
Max drawdown: −99.99%
Sharpe ratio: 0.06

Growth of $10,000

Trailing returns (%)

SLS's average annual return was −48.65% over the last 10 years, through Nov 12, 2026. $10,000 in SLS on Nov 11, 2016 fell to $13 by Nov 12, 2026, with dividends reinvested.

	Total	Per year
SLS	−32.69	−31.78	+53.83	+113.00	+438.93	+106.64	+2.26	−48.65	−40.82	−43.25

Total

1M: −32.69%
3M: −31.78%
6M: +53.83%
YTD: +113.00%
1Y: +438.93%

Per year

3Y: +106.64%
5Y: +2.26%
10Y: −48.65%
15Y: −40.82%
Since 2008: −43.25%

Annual returns

2008 from Mar 12 · 2026 through Nov 12

SLS returns by year

Year	Return
2026 through Nov 12	+113.00%
2025	+262.50%
2024	−1.89%
2023	−55.08%
2022	−57.32%
2021	−4.82%
2020	+35.12%
2019	−93.01%
2018	−84.23%
2017	−86.60%
2016	−93.40%
2015	−2.65%
2014	−69.56%
2013	+224.18%
2012	+225.53%
2011	−81.78%
2010	−43.67%
2009	−20.35%
2008 from Mar 12	−45.29%

Metrics

Since 2008

Volatility	116.02%
Sortino ratio	0.11
Calmar ratio	−0.43
Best year, 2025	+262.50%
Worst year, 2016	−93.40%
Positive years	4 of 17
Longest drawdown	18.7 years

Worst drawdowns

Since 2008

Decline	Peak	Bottom	Recovered	Length
−99.9%	Mar 2008	Jan 2024	Not yet	18.7 years so far